Akamai Technologies (AKAM) — Q2 2026 Earnings Preview

Company

Akamai Technologies, Inc.

Ticker

NASDAQ: AKAM

Reporting Period

Q2 2026 (quarter ended June 30, 2026)

Earnings Date

August 6, 2026 (after market close)

Preparation Date

August 5, 2026

Sector ETF Benchmark

IGV (iShares Expanded Tech-Software ETF)

1. Earnings Preview

Key Takeaway: Setup is mixed — consensus is a manageable bar on revenue but the wide EPS guidance range ($1.45–$1.65) creates meaningful uncertainty; the single biggest swing factor is whether CIS revenue ramp and GPU delivery progress in Q2 can offset the margin compression from the unprecedented CapEx surge.

Heading into AKAM's Q2 2026 print, the setup is nuanced: revenue consensus of ~$1.09B sits comfortably within management's guided range of $1.075–$1.10B, making a top-line beat or in-line result the base case, but the wide non-GAAP EPS guidance range ($1.45–$1.65) — driven by the timing and magnitude of GPU deliveries and associated depreciation — leaves the bottom line as the key variable. Management's tone since the May 7 earnings call has been decidedly confident, punctuated by the landmark $1.8B CIS deal and the subsequent $2.6B convertible note offering to fund the build-out, signaling conviction in the demand pipeline. Estimate revisions have been broadly stable since the post-Q1 baseline, with the street largely accepting management's guidance framework rather than diverging materially, though full-year EPS consensus of ~$6.69 sits near the midpoint of the $6.40–$7.15 guided range — a wide band that reflects genuine uncertainty around depreciation timing. The stock surged ~27% on the Q1 print on the $1.8B deal announcement, but has since given back most of those gains, trading near ~$122 heading into the print, suggesting the market has partially de-rated the stock as CapEx intensity and margin compression concerns have weighed on sentiment. The key wildcard is whether management provides any update on additional GPU orders beyond the current guide — the Q1 call explicitly flagged that the GPU pipeline significantly exceeds existing inventory and that additional orders in H2 2026 are possible but not yet in guidance, which could either be a positive catalyst (more demand) or a negative one (more CapEx, more margin pressure).

2. KPIs & Consensus Expectations

Key Takeaway: Consensus is a manageable bar on revenue (within guidance range), but the EPS bar is the bigger swing factor given the wide guided range driven by GPU depreciation timing; CIS revenue growth trajectory is the most watched KPI heading into the print.

Table 1 — Q2 2026 Current Quarter Snapshot

KPI

Q1 2026 Actual

Q2 2025 Actual (Prior Year)

Q2 2026 Consensus Est.

YoY Change

Q2 2026 Guidance

Cons. vs. Guidance Mid

Total Revenue ($M)

$1,073.6

$1,043.5

$1,093.1

+4.8% YoY

$1,075–$1,100M

+0.3% vs. $1,087.5M mid

Security Revenue ($M)

$589.8

$551.9

$600.6

+8.8% YoY

High single digits CC growth (FY)

Tracking guidance

Cloud Infrastructure Services (CIS) Revenue ($M)

$94.6

$71.5

$101.7

+42.3% YoY

≥50% CC growth (FY 2026)

Tracking / above pace

Delivery Revenue ($M)

$294.2

$320.1

$298.2

-6.8% YoY

Mid-single digit decline CC (FY)

Tracking guidance

Non-GAAP EPS (Diluted)

$1.61

$1.73

$1.58

-8.7% YoY

$1.45–$1.65

-0.8% vs. $1.55 mid

Non-GAAP Operating Income ($M)

$282.8

$308.6

$278.2

-9.9% YoY

~25–26% op. margin

Tracking guidance

Adjusted EBITDA ($M)

$426.7

$444.4

$422.6

-4.9% YoY

~38–39% EBITDA margin

Tracking guidance

CapEx — Accrual Basis ($M)

$118.9

$135.6

$269.0

+98.4% YoY

$433–$453M (cash basis)

N/A — accrual vs. cash timing

Free Cash Flow ($M)

$120.7

$235.4

$42.1

-82.1% YoY

Negative FY 2026 (CapEx surge)

Tracking guidance

Source: Visible Alpha consensus and actuals data. All figures in USD millions unless noted. CIS = Cloud Infrastructure Services. CC = constant currency. Q2 2026 consensus as of August 5, 2026.

Table 2 — Beat/Miss History (Last 8 Quarters)

Top KPI #1: Total Revenue | Top KPI #2: Non-GAAP EPS (Diluted)

Quarter

Revenue Reported ($M)

Revenue Consensus ($M)

Rev. Surprise %

EPS Reported

EPS Consensus

EPS Surprise %

Result

Q1 2026

$1,073.6

$1,073.9

0.0%

$1.61

$1.60

+0.6%

In Line / In Line

Q4 2025

$1,094.9

$1,077.2

+1.6%

$1.84

$1.77

+4.0%

Beat / Beat

Q3 2025

$1,054.6

$1,044.0

+1.0%

$1.86

$1.64

+13.4%

Beat / Beat

Q2 2025

$1,043.5

$1,020.8

+2.2%

$1.73

$1.56

+10.9%

Beat / Beat

Q1 2025

$1,015.1

$1,012.0

+0.3%

$1.70

$1.57

+8.3%

In Line / Beat

Q4 2024

$1,019.9

$1,015.9

+0.4%

$1.66

$1.52

+9.2%

In Line / Beat

Q3 2024

$1,004.7

$1,000.4

+0.4%

$1.59

$1.59

0.0%

In Line / In Line

Q2 2024

$979.6

$977.5

+0.2%

$1.58

$1.53

+3.3%

In Line / Beat

Source: Visible Alpha consensus and actuals data. Pattern: AKAM has a strong track record of beating or meeting revenue consensus (8 for 8 over the last 8 quarters), while EPS beats have been consistent and often material — the exception being Q1 2026 where the wide guidance range and CapEx surge compressed the beat to near-zero. The Q2 2026 EPS bar is the lowest in 8 quarters ($1.58 consensus vs. $1.73 a year ago), reflecting the market's acknowledgment of margin headwinds from the GPU build-out.

3. Guidance & Commentary Evolution

Key Takeaway: Management's posture has shifted to highly confident since the Q1 print, with the $2.6B convertible note offering (May 18) representing a material post-earnings capital action that signals conviction in the CIS demand pipeline; no formal guidance revision has been issued, but the financing action implicitly validates the upper end of the CapEx and growth outlook.

Metric

Initial Guidance (Q1 2026 Earnings — May 7, 2026)

Revised Guidance

Current Consensus

Note

Q2 2026 Revenue

$1,075–$1,100M (+3–5% YoY)

$1,093.1M

Unchanged; consensus sits near high end of range

Q2 2026 Non-GAAP EPS

$1.45–$1.65

$1.58

Unchanged; wide range reflects GPU depreciation timing uncertainty

Q2 2026 Non-GAAP Op. Margin

~25–26%

~25.4% (implied by consensus)

Unchanged; significant step-down from ~26.3% in Q1

Q2 2026 CapEx (Cash Basis)

$433–$453M (~40–41% of revenue)

$269M (accrual basis consensus)

Unchanged; Q2 CapEx jump driven by NVIDIA GPU deliveries beginning + Q1 timing catch-up

FY 2026 Revenue

$4,445–$4,550M (+6–8% YoY)

$4,501.3M

Unchanged; consensus near midpoint

FY 2026 Non-GAAP EPS

$6.40–$7.15

$6.69

Unchanged; wide range reflects depreciation timing; consensus near midpoint

FY 2026 CIS Revenue Growth

≥50% YoY CC (raised from 45–50%)

~$475M FY (implied ~50%+ growth)

Raised at Q1 earnings; driven by $1.8B deal ramp in H2 2026

FY 2026 CapEx (% of Revenue)

~40–42% of revenue (raised from 23–26%)

~$594.6M (accrual basis consensus)

↑ Dramatically raised at Q1 earnings; $700M of $1.8B deal CapEx in H2 2026

FY 2026 Non-GAAP Op. Margin

~26% (narrowed from 26–28%)

~26% (implied)

↓ Narrowed at Q1 earnings; investing ahead of revenue for CIS build-out

Capital Structure

$1.7B cash + $1B credit facility (as of Q1)

$2.6B convertible note offering (May 18, 2026)

N/A

↑ Post-earnings capital action; proceeds fund CIS CapEx + ~$350M share buyback

4. Guidance vs. Estimate Revision Tracker

Key Takeaway: Estimates have been remarkably stable since the post-Q1 baseline — the street has largely anchored to management's guidance midpoints rather than diverging — but the wide EPS range means the consensus estimate carries more uncertainty than the number alone suggests; CIS revenue estimates are tracking at or above the ≥50% growth guidance pace.

KPI (Period)

Estimate ~5 Days Post Q1 Earnings (as of May 12, 2026)

Current Consensus (Aug 5, 2026)

Estimate Δ (%)

Initial Guidance (Q1 Earnings Call)

Current Guidance

Guidance Δ

Cons. vs. Guidance Mid

Total Revenue — Q2 2026

$1,093.1M

$1,093.1M

0.0%

$1,075–$1,100M

Unchanged

+0.5% vs. mid

Total Revenue — FY 2026

$4,500.5M

$4,501.3M

+0.0%

$4,445–$4,550M

Unchanged

+0.0% vs. mid

Non-GAAP EPS — Q2 2026

$1.59

$1.58

-0.6%

$1.45–$1.65

Unchanged

+1.9% vs. mid ($1.55)

Non-GAAP EPS — FY 2026

$6.68

$6.69

+0.1%

$6.40–$7.15

Unchanged

-0.7% vs. mid ($6.775)

CIS Revenue — Q2 2026

$102.0M

$101.7M

-0.3%

≥50% CC growth (FY)

Unchanged

~42% YoY — tracking to FY pace

CIS Revenue — FY 2026

$474.9M

$475.2M

+0.1%

≥50% CC growth (FY)

Unchanged

~50%+ YoY — at/above guidance floor

Non-GAAP Op. Income — Q2 2026

$278.6M

$278.2M

-0.1%

~25–26% margin

Unchanged

~25.4% — tracking guidance

Free Cash Flow — FY 2026

-$68.3M

-$85.5M

-25.1%

Negative (CapEx surge)

Unchanged

FCF estimates drifting more negative

Source: Visible Alpha consensus and actuals data. Post-Q1 baseline as of May 12, 2026 (5 trading days after May 7 earnings). Commentary: The near-zero estimate revisions since the Q1 print reflect the street's acceptance of management's guidance framework. The key risk is that the wide EPS range ($1.45–$1.65) means a $0.10 miss vs. consensus is still within guidance — the market may react more to the qualitative commentary on GPU delivery progress and H2 CIS ramp than to the headline EPS number itself.

5. Stock Performance

Key Takeaway: AKAM surged ~27% on the Q1 earnings day (May 8) driven entirely by the $1.8B CIS deal announcement, but has since given back all gains and then some, underperforming both SPY (+5.4%) and IGV (+12.3%) since the earnings date — the de-rating reflects investor concern about CapEx intensity, margin compression, and the long payback period of the GPU build-out rather than any deterioration in the underlying business.

AKAM vs. IGV (iShares Expanded Tech-Software ETF) vs. S&P 500 (SPY) — Indexed to 100 at May 7, 2026 (Q1 2026 Earnings Date). Source: Yahoo Finance.

Performance Summary (May 7 – Aug 4, 2026): AKAM +5.7% | IGV +12.3% | SPY +5.4%. AKAM's post-earnings spike to ~$161 (May 13 intraday high) on the $1.8B deal euphoria quickly faded as investors digested the CapEx implications. The $2.6B convertible note offering on May 18 initially pressured the stock (dilution concerns), and AKAM has trended lower through June and July, reaching a trough near $107 on July 29 before recovering modestly to ~$122 heading into the Q2 print. The stock's underperformance vs. IGV is notable given the broader software sector rally — suggesting AKAM is being valued more as a capital-intensive infrastructure company than a software/security compounder during this investment phase.

6. Peer Commentaries — Q2 2026 Read-Throughs (Last 60 Days)

Key Takeaway: Peer commentary from the last 60 days is broadly positive for AKAM's two core businesses: security peers (PANW, CRWD, FTNT) are reporting accelerating demand driven by AI-powered threats and enterprise urgency — a direct tailwind for AKAM's security portfolio; and hyperscaler commentary (AMZN, MSFT, GOOGL) confirms that AI infrastructure demand is exceeding supply and that distributed/edge compute is a structural growth theme — validating AKAM's CIS investment thesis. FSLY's CDN read-through is constructive: strong traffic growth and security momentum are positive for AKAM's delivery and security businesses.

Security Peers — Demand Environment Read-Through

Cloud Infrastructure & CDN Peers — AI Demand & Edge Computing Read-Through

7. Material News & Developments

Key Takeaway: The most important development since the Q1 print is the $2.6B convertible note offering (May 18), which materially changes AKAM's capital structure and signals management's conviction in the CIS demand pipeline; the secondary implication is that the company is now explicitly financing its GPU build-out through capital markets rather than solely from operating cash flow, which investors will scrutinize for execution risk.

8. Insider Transaction Activity

Key Takeaway: All insider transactions since the Q1 earnings date are 10b5-1 planned sales — no discretionary open-market selling and no open-market buying. The absence of discretionary insider buying despite the stock's significant pullback from its post-earnings highs (~$161 to ~$122) is notable but not alarming given the 10b5-1 plan context; the planned sales are routine and obligation-driven.

Name

Title

Transaction Type

Shares

Date

Note

Joseph Paul C

EVP — Global Sales

10b5-1 Planned Sale

3,100

July 15, 2026

Pre-planned; routine 10b5-1 plan execution

Blumofe Robert

Chief Technology Officer

10b5-1 Planned Sale

243

June 18, 2026

Pre-planned; routine 10b5-1 plan execution

Salem-Jackson Kim

EVP, Chief Marketing Officer

10b5-1 Planned Sale

2,300

June 10, 2026

Pre-planned; routine 10b5-1 plan execution

Howell Laura

SVP, Chief Accounting Officer

RSU Vest + Tax Withholding Sale

95 (withheld)

June 12, 2026

322 RSUs vested; 95 shares withheld for taxes; not a discretionary sale

Source: SEC Form 4 filings. Note: All open-market transactions since the Q1 2026 earnings date (May 7, 2026) are 10b5-1 pre-planned sales or RSU-related tax withholding — none are discretionary open-market buys or sells. No open-market purchases were filed during the period. The company itself executed share repurchases as part of the $2.6B convertible note offering (approximately $350M in concurrent buybacks from note purchasers at the offering price on May 18, 2026), which represents the most significant capital return action in the period.